←Back to Expert Scholars
Translational Medicine / 转化医学HPV-Negative Head and Neck Cancer
Robert Haddad
MD
🏢Dana-Farber Cancer Institute🌐USA
Chief, Head and Neck Oncology
65
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Robert Haddad leads head and neck oncology at Dana-Farber and has made significant contributions to treatment of HPV-negative HNSCC. His research addresses induction chemotherapy approaches and immunotherapy combinations for this aggressive disease subtype. He co-leads the Harvard/Dana-Farber head and neck cancer program.
Share:
🧪Research Fields 研究领域
HPV-negative HNSCC
Induction chemotherapy
Immunotherapy
Recurrent HNSCC
Multidisciplinary care
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Robert Haddad 的研究动态
Follow Robert Haddad's research updates
留下邮箱，当我们发布与 Robert Haddad（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment